/ONCO.CN
ONCO.CN Stock - Onco-Innovations Ltd.
Healthcare|BiotechnologyCNQ
$1.47-1.27%
$0.02 (-1.27%) • May 21
42
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.31
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.0
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1.62
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ONCO.CN
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.46 – $1.48
TARGET (TP)$1.69
STOP LOSS$1.35
RISK/REWARD1:1.8
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta8.62
52W High$2.80
52W Low$0.56
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2023 | FY2022 |
|---|---|---|
| Revenue | N/A | N/A |
| Gross Profit | N/A | N/A |
| Gross Margin | N/A | N/A |
| Operating Income | N/A | N/A |
| Net Income | $-420,654 | $-234 |
| Net Margin | N/A | N/A |
| EPS | $-0.01 | $-0.00 |
Company Overview
Onco-Innovations Ltd. is a Canadian biotech company, which engages in cancer research and treatment, specializing in oncology. Its product includes the ONC010 for cancer treatments. The company was founded on September 16, 2021 and is headquartered in Calgary, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
ONCO.CNLoading earnings data...
Latest News
Loading news...
Frequently Asked Questions about ONCO.CN
What is ONCO.CN's current stock price?
Onco-Innovations Ltd. (ONCO.CN) is currently trading at $1.47 per share. The stock has moved -1.27% today.
What is the analyst price target for ONCO.CN?
No analyst price targets are currently available for this stock.
What sector is Onco-Innovations Ltd. in?
Onco-Innovations Ltd. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the CNQ exchange.
What is ONCO.CN's market cap?
Onco-Innovations Ltd. has a market capitalization of $0.06 billion, making it a small-cap company.
Does ONCO.CN pay dividends?
No, Onco-Innovations Ltd. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAEZS.TO
Aeterna Zentaris Inc.
$8.29
Mkt Cap: $0.0B
AIDR.CN
Rocket Doctor AI Inc.
$0.70
Mkt Cap: $0.1B
DRDR.TO
MCI Onehealth Technologies Inc.
$0.55
Mkt Cap: $0.0B
IBT.V
IBEX Technologies Inc.
$1.45
Mkt Cap: $0.0B
IGX.TO
IntelGenx Technologies Corp.
$0.24
Mkt Cap: $0.0B
MSCL.V
Satellos Bioscience Inc.
$0.56
Mkt Cap: $0.1B
MSET.CN
Mindset Pharma Inc.
$0.74
Mkt Cap: $0.1B
PMN.TO
ProMIS Neurosciences, Inc.
$6.00
Mkt Cap: $0.1B
STEM.CN
Stem Holdings, Inc.
$0.31
Mkt Cap: $0.1B
TGOD.CN
The Green Organic Dutchman Holdings Ltd.
$0.38
Mkt Cap: $0.1B
Explore stocks similar to ONCO.CN for comparison